IgA Nephropathy After SARS-CoV-2 Vaccination

IgA Nephropathy After SARS-CoV-2 Vaccination

Here we present the first case of newly diagnosed IgA nephropathy (IgAN) after a SARS-CoV-2 vaccination. A 30-year-old man with no known past medical history presented with gross hematuria and subnephrotic proteinuria 24 hours after the second dose of the mRNA-1273 SARS-CoV-2 vaccine. A kidney biops...

Full description

Bibliographic Details
Main Authors:	Matthew Abramson, Samuel Mon-Wei Yu, Kirk N. Campbell, Miriam Chung, Fadi Salem
Format:	Article
Language:	English
Published:	Elsevier 2021-09-01
Series:	Kidney Medicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590059521001552

Similar Items

Hematuria in patients with IgA nephropathy after vaccine for SARS-CoV-2
by: Leonardo Calle Garcia, et al.
Published: (2023-09-01)

Sibling cases of gross hematuria and newly diagnosed IgA nephropathy following SARS-CoV-2 vaccination
by: Yuri Uchiyama, et al.
Published: (2022-06-01)

IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection
by: Isabella Quinti, et al.
Published: (2021-04-01)

Development of IgA vasculitis after SARS‐CoV‐2 vaccination
by: Yasuaki Ogura, et al.
Published: (2022-10-01)

Abnormal Aspects of IgA in IgA Nephropathy
by: Akash Nabil, et al.
Published: (2000-01-01)

Bortezomib for Reduction of Proteinuria in IgA Nephropathy
by: Choli Hartono, et al.
Published: (2018-07-01)

The Potential Role of an Aberrant Mucosal Immune Response to SARS-CoV-2 in the Pathogenesis of IgA Nephropathy
by: Zhao Zhang, et al.
Published: (2021-07-01)

Identification the genetic influence of SARS-CoV-2 infections on IgA nephropathy based on bioinformatics method.
by: Xiaoqi Deng, et al.
Published: (2023-04-01)

IgA Vasculitis and IgA Nephropathy: Same Disease?
by: Evangeline Pillebout
Published: (2021-05-01)

Immunosupression in IgA Nephropathy
by: Ileana Peride, et al.
Published: (2022-03-01)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
by: Manliu Wang, et al.
Published: (2020-02-01)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
by: Marios Papasotiriou, et al.
Published: (2022-02-01)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
by: Yoshihito Nihei, et al.
Published: (2023-04-01)

Gross Hematuria Following SARS-CoV-2 Infection in IgA Nephropathy: A Report of 5 Cases
by: Hiroyuki Ueda, et al.
Published: (2023-06-01)

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
by: Maciej Tota, et al.
Published: (2023-04-01)

The origin and activities of IgA1-containing immune complexes in IgA nephropathy
by: Barbora eKnoppova, et al.
Published: (2016-04-01)

SARS-CoV-2 induced IgA vasculitis confirmed with SARS-CoV-2 tissue testing
by: Ahmed N. Ansari, MD, et al.
Published: (2024-01-01)

Nefropatia por IgA nas espondiloartrites IgA nephropathy in spondyloarthritis
by: Daniela Castelo Azevedo, et al.
Published: (2011-02-01)

An Update on the Genetics of IgA Nephropathy
by: Lin-Lin Xu, et al.
Published: (2023-12-01)

Hyperuricemia Aggravates IgA Nephropathy
by: Mahmoud Rafieian-Kopaei, et al.
Published: (2013-11-01)

An update on pathology of IgA nephropathy
by: Maria Fernanda Soares

MicroRNAs in IgA nephropathy
by: Xingchen Yao, et al.
Published: (2021-01-01)

Predictors of prognosis in IgA nephropathy
by: Yasuhiko Tomino
Published: (2012-10-01)

Ways of Treating IgA Nephropathies
by: Wardle E
Published: (2000-01-01)

IgA nephropathy with leucocytoclastic vasculitis
by: Lin-Yan Wei, et al.
Published: (2018-07-01)

Tuberculosis-associated IgA nephropathy
by: Yamei Wang, et al.
Published: (2018-07-01)

RETRACTED: Association of aldosterone synthase () gene polymorphism with IgA nephropathy risk and progression of IgA nephropathy
by: Weiqiang Zhong, et al.
Published: (2015-09-01)

Development of SARS-CoV-2 specific IgG and IgA antibodies in serum and milk with different SARS-COV-2 vaccines in lactating women
by: Carolina Lechosa-Muñiz, et al.
Published: (2023-01-01)

Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy.
by: William J Placzek, et al.
Published: (2018-01-01)

Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy.
by: Kazuo Takahashi, et al.
Published: (2014-01-01)

IgG and IgA Antibodies Post SARS-CoV-2 Vaccine in the Breast Milk and Sera of Breastfeeding Women
by: Federica Scrimin, et al.
Published: (2022-01-01)

Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review.
by: Qiang Sun, et al.
Published: (2016-01-01)

Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?
by: Jia-Wei He, et al.
Published: (2022-03-01)

Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy
by: Pei Chen, et al.
Published: (2018-10-01)

Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study
by: Marta Selma-Royo, et al.
Published: (2022-04-01)

Heterologous SARS‐CoV‐2 IgA neutralising antibody responses in convalescent plasma
by: Samantha K Davis, et al.
Published: (2022-01-01)

IgA Nephropathy: Beyond the Half-Century
by: Yoshio Shimizu, et al.
Published: (2023-12-01)

Role of telitacicept in the treatment of IgA nephropathy
by: Lijun Wu, et al.
Published: (2023-09-01)

History of IgA Nephropathy Mouse Models
by: Batoul Wehbi, et al.
Published: (2021-07-01)

Emerging Modes of Treatment of IgA Nephropathy
by: Dita Maixnerova, et al.
Published: (2020-11-01)